FTC Release: FTC Secures Major Settlement with Caremark, Resolving Antitrust Case Against Second Drug Middleman
Dow Jones02:50
Settlement will drive down patients' out-of-pocket costs, increase transparency and ensure community pharmacies are treated fairly
The Federal Trade Commission secured a settlement agreement with one of the nation's largest pharmacy benefit managers (PBMs) and its affiliated entities, marking yet another important victory in the Commission's fight to lower healthcare costs for Americans.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
